COLGATE PALMOLIVE CO
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B |
| Cost of revenue | $8.1B | $7.9B | $8.1B | $7.7B | $7.0B |
| Gross profit | $12.3B | $12.2B | $11.3B | $10.2B | $10.4B |
| Selling, general & administrative | $7.9B | $7.7B | $7.2B | $6.6B | $6.4B |
| Research and development | $366.0M | $355.0M | $343.0M | $320.0M | $307.0M |
| Operating income | $3.3B | $4.3B | $4.0B | $2.9B | $3.3B |
| Interest expense | $267.0M | $292.0M | $287.0M | $167.0M | — |
| Pretax income | $3.1B | $4.0B | $3.4B | $2.7B | $3.1B |
| Income tax expense | $798.0M | $907.0M | $937.0M | $693.0M | $749.0M |
| Net income | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B |
| Balance Sheet | |||||
| Cash and equivalents | $1.3B | $1.1B | $966.0M | $775.0M | $832.0M |
| Current assets | $5.7B | $5.3B | $5.3B | $5.1B | $4.4B |
| Total assets | $16.3B | $16.0B | $16.4B | $15.7B | $15.0B |
| Current liabilities | $6.9B | $5.8B | $4.7B | $4.0B | $4.1B |
| Total liabilities | $16.0B | $15.5B | $15.4B | $14.9B | $14.1B |
| Stockholders' equity | $54.0M | $212.0M | $609.0M | $401.0M | $609.0M |
| Cash Flow Statement | |||||
| Cash from operations | $4.2B | $4.1B | $3.7B | $2.6B | $3.3B |
| Depreciation and amortization | $630.0M | $605.0M | $567.0M | $545.0M | $556.0M |
| Stock-based compensation | $155.0M | $135.0M | $122.0M | $125.0M | $135.0M |
| Capital expenditure | $564.0M | $561.0M | $705.0M | $696.0M | $567.0M |
| Free cash flow | $3.6B | $3.5B | $3.0B | $1.9B | $2.8B |
| Dividends paid | $1.8B | $1.8B | $1.7B | $1.7B | $1.7B |
| Share repurchases | $1.2B | $1.7B | $1.1B | $1.3B | $1.3B |
| Impairments | $582.0M | — | $0 | $332.0M | $367.0M |
Shares outstanding 800.2M · Free float 99.6%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- May 13, 2026 8-K
- May 1, 2026 10-Q
- May 1, 2026 8-K
- April 9, 2026 8-K
- March 17, 2026 8-K
- March 12, 2026 8-K
- February 23, 2026 10-K
- January 30, 2026 8-K